EP0692965A4 - Verfahren und präparat zur behandlung von osteoporose - Google Patents

Verfahren und präparat zur behandlung von osteoporose

Info

Publication number
EP0692965A4
EP0692965A4 EP94913970A EP94913970A EP0692965A4 EP 0692965 A4 EP0692965 A4 EP 0692965A4 EP 94913970 A EP94913970 A EP 94913970A EP 94913970 A EP94913970 A EP 94913970A EP 0692965 A4 EP0692965 A4 EP 0692965A4
Authority
EP
European Patent Office
Prior art keywords
osteoporosis
treatment
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP94913970A
Other languages
English (en)
French (fr)
Other versions
EP0692965A1 (de
Inventor
R Curtis Morris Jr
Anthony Sebastian
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California Berkeley
University of California San Diego UCSD
Original Assignee
University of California Berkeley
University of California San Diego UCSD
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California Berkeley, University of California San Diego UCSD filed Critical University of California Berkeley
Publication of EP0692965A1 publication Critical patent/EP0692965A1/de
Publication of EP0692965A4 publication Critical patent/EP0692965A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Inorganic Chemistry (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EP94913970A 1993-04-02 1994-03-29 Verfahren und präparat zur behandlung von osteoporose Withdrawn EP0692965A4 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4234993A 1993-04-02 1993-04-02
PCT/US1994/003402 WO1994022457A1 (en) 1993-04-02 1994-03-29 Method and composition for treatment of osteoporosis
US42349 2002-01-08

Publications (2)

Publication Number Publication Date
EP0692965A1 EP0692965A1 (de) 1996-01-24
EP0692965A4 true EP0692965A4 (de) 1998-08-12

Family

ID=21921399

Family Applications (1)

Application Number Title Priority Date Filing Date
EP94913970A Withdrawn EP0692965A4 (de) 1993-04-02 1994-03-29 Verfahren und präparat zur behandlung von osteoporose

Country Status (8)

Country Link
EP (1) EP0692965A4 (de)
JP (1) JPH08508502A (de)
KR (1) KR960701642A (de)
CN (1) CN1120314A (de)
AU (1) AU692155B2 (de)
BR (1) BR9406101A (de)
CA (1) CA2159354A1 (de)
WO (1) WO1994022457A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0208165A (pt) * 2001-03-16 2004-03-30 Wyeth Corp Composições farmacêuticas e seus usos na terapia de reposição de estrogênio
AU2004264899A1 (en) * 2003-08-06 2005-02-24 Innophos, Inc. Method for promoting bone growth
US10221116B2 (en) * 2014-04-02 2019-03-05 Shell Oil Company Process for the separation of monoethylene glycol and 1,2-butanediol

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3608077A (en) * 1969-11-13 1971-09-21 Syntex Corp Stabilization of metal steroid alcohol sulfates
EP0220844A2 (de) * 1985-10-22 1987-05-06 University Of Florida Verwendung von Östrogen-dihydropyridinverbindungen zur Gewichtsreglung
US5171583A (en) * 1988-10-21 1992-12-15 The Regents Of The University Of California Treatment of osteoporosis using potassium bicarbonate

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4078060A (en) * 1976-05-10 1978-03-07 Richardson-Merrell Inc. Method of inducing an estrogenic response
US4261985A (en) * 1978-11-22 1981-04-14 Ciba-Geigy Corporation Novel diuretics
US4814177A (en) * 1986-03-18 1989-03-21 Board Of Regents, University Of Texas System Ultradense and more soluble and bioavailable preparations of calcium citrate

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3608077A (en) * 1969-11-13 1971-09-21 Syntex Corp Stabilization of metal steroid alcohol sulfates
EP0220844A2 (de) * 1985-10-22 1987-05-06 University Of Florida Verwendung von Östrogen-dihydropyridinverbindungen zur Gewichtsreglung
US5171583A (en) * 1988-10-21 1992-12-15 The Regents Of The University Of California Treatment of osteoporosis using potassium bicarbonate

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO9422457A1 *

Also Published As

Publication number Publication date
EP0692965A1 (de) 1996-01-24
CN1120314A (zh) 1996-04-10
WO1994022457A1 (en) 1994-10-13
AU6621994A (en) 1994-10-24
CA2159354A1 (en) 1994-10-13
BR9406101A (pt) 1995-12-19
JPH08508502A (ja) 1996-09-10
AU692155B2 (en) 1998-06-04
KR960701642A (ko) 1996-03-28

Similar Documents

Publication Publication Date Title
FR2739255B1 (fr) Composition antiparasitaire pour le traitement et la protection des animaux de compagnie
BR9407799A (pt) Composição de matéria método de tratamento e composição farmaceutica
EP0754042A4 (de) Behandlung von atherosklerose mit imidazolen, die den angiotensin ii-rezeptor blockieren
EP0784464A4 (de) Präparat und verfahren zur haarbehandlung
EP0661966A4 (de) Zusammensetzung und verfahren zur ulcusprävention und -behandlung.
EP0792371A4 (de) Kombinationsverfahren zur aknebehandlung
EP0831924A4 (de) Verfahren zur behandlung von asthma
DZ1716A1 (fr) Méthode et mécanisme pour l'enlevement et le traitement des déchets.
IT9048260A0 (it) Composizione farmaceutica per il trattamento di disturbi respiratori e metodo per la sua applicazione.
IT1247784B (it) Composizione e metodo per la riduzione dell'appetito
EP0746301A4 (de) Selbstbräunende kosmetische mittel und verfahren für ihre verwendung
EP0643154A3 (de) Zusammensetzung und Verfahren zur Oberflächenbehandlung von Kupfer und Kupferlegierungen.
EP1014972A4 (de) Verfahren zur behandlung und arzneimittel
IT9048261A0 (it) Composizione farmaceutica per il trattamento di disturbi respiratori e metodo per la sua applicazione.
FI915287A7 (fi) Jäteveden käsittelymenetelmä ja koostumus
GB9324234D0 (en) Treatment of agriculture waste
ZA931778B (en) Method and composition for the treatment of osteoporosis
FR2501033B1 (fr) Plaque pour l'osteosynthese de l'epiphyse inferieure du femur et ensemble plaque-vis en faisant application
EP0844017A4 (de) Prozess zur herstellung eines emulgators und emulgierte zusammensetzung
FR2741355B1 (fr) Composition pour le traitement d'objets que l'on souhaite nettoyer et/ou desinfecter
IT1271567B (it) Procedimento per l'ulteriore trattamento di salcicce
FR2641964B1 (fr) Activateurs-gouttieres pour traitements d'orthopedie dento-faciale et parodontologie
FR2558372B1 (fr) Composition medicamenteuse pour le traitement de l'acne
ITMI932095A1 (it) Metodo e disposizione per controllare processi tecnologici e/o per determinare la fine di detti processi
EP0692965A4 (de) Verfahren und präparat zur behandlung von osteoporose

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19951011

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI NL PT SE

AX Request for extension of the european patent

Free format text: SI PAYMENT 951011

RAX Requested extension states of the european patent have changed

Free format text: SI PAYMENT 951011

RHK1 Main classification (correction)

Ipc: A61K 31/565

A4 Supplementary search report drawn up and despatched
AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI NL PT SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19980919